Submitted by Anonymous (not verified) on 19 September 2024 - 10:50
Opinion/decision on a Paediatric investigation plan (PIP): Padcev, Enfortumab vedotin, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Oncology, PIP number: P/0385/2023
Source: